News About: Pharm. Industry
Prosecution to search and seize Novartis Korea on suspicion of illegal rebates
Novartis Korea was known to be searched and seized on suspicion of illegal rebates.
On the 22nd, the joint investigation team for pharmaceutical rebates(Chief Prosecutor Cheol-hyung Byun, Director) at the Seoul Weste...
Foreign companies to reduce ‘certain standard expenses’ and adopt Wage Peak System
Multinational pharmaceutical companies on a streak have started to tighten their business.
According to the industry concerned on the 23rd, an U.S. company and a European company reduced so-called ‘expenses to keep u...
Genzyme reborn as Sanofi-Genzyme Korea
A pharmaceutical company specializing in rare diseases, Genzyme has been re-born as a Sanofi Group’s ‘Sanofi Genzyme’ department.
According to the industry concerned on the 19th, the Sanofi’s Korean branch confirmed ...
Celltrion acquires substance patent of Herceptin biobetterCelltrion acquired a patent of the Antibody-Drug Conjugate(ADC) substance, a new drug treating breast cancer, from the Korean Intellectual Property Office on the 18th.
The pate...
|
Hanmi wins Viagra’s design trialsA Hanmi Pharm’s erectile dysfunction treatment, Palpal was finally confirmed not to infringe the Viagra’s trademark right.
On the 18th, the 4th Civil Division, Seoul High Court...
|
Zantac Tab will be resupplied from this JulyA drug which has experienced the long-term out-of-stock crisis from the second half of the last year to this February due to the Tianjin explosion, Zantac is expected to be re-s...
|
Hanmi Pharm launches Korea’s first modified drug for influenza, ‘Hanmi Flu’Hanmi Pharm(CEO Kwan-soon Lee, www.hanmi.co.kr) announced to launch Hanmi Flu, the Korea’s first incrementally modified drug for influenza on the 16th.
The company stated Hanmi...
|
Celltrion, “Biogen’s confirmation trials are only a part of procedures for the Patent Linkage System”When it comes to the 3 active confirmation trials for the scope of the right, which was filed by Biogen over CT-P10(product name: Truxima) against Celltrion, Celltrion expressed...
|
Daehwa Pharmaceutical accelerates to launch the world’s first oral paclitaxel antibodyDaehwa Pharmaceutical announced it applied manufacturing, sales and product approvals of ‘DHP107,’ the world’s first oral paclitaxel-type modified drug, to the Ministry of Food ...
|
Domestic new drugs fly with business abilities of large pharmaceutical companies
Increasing domestic new drugs’ prescriptions through the business abilities of large pharmaceutical companies, the joint promotion trend among domestic companies has been settled.
According to the industry on the 15t...
